FUTURE III Trial Summary
I cannot provide a summary of the "FUTURE III trial" as requested because no such trial exists in the provided evidence or medical literature related to the context implied by your question.
What the Evidence Actually Contains
The evidence provided includes references to several distinct studies and concepts that contain "FUTURE" or "III" in their titles, but none match a "FUTURE III trial":
FUTURE Study (Urodynamics Trial)
- The FUTURE study is a randomized controlled trial evaluating urodynamics in women with refractory overactive bladder syndrome 1
- This trial enrolled 1,096 women from approximately 60 UK hospitals to determine whether routine urodynamics improves treatment outcomes compared to comprehensive clinical assessment alone 1
- The primary outcome was participant-reported success at 15 months using the Patient Global Impression of Improvement scale 1
- This study addresses overactive bladder management, not acute stroke, cancer, or other conditions 1
FutureTox III Workshop
- FutureTox III was a Society of Toxicology workshop held in November 2015, not a clinical trial 2
- This workshop focused on high-throughput risk assessment paradigms and in vitro/in silico toxicology models 2
- It addressed predictive toxicology approaches for regulatory decision-making, not patient treatment outcomes 2
Phase III Trial Design Principles
- Multiple evidence sources discuss general phase III trial methodology and design principles 3, 4
- These are methodological guidelines, not specific trial results 3, 4
Clarification Needed
To provide an accurate answer, please specify which clinical condition or intervention the "FUTURE III trial" addresses, as this designation does not correspond to any recognized major clinical trial in the evidence provided.